Update

Optimapharm continues global expansion with new offices in the UK

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/stanciuc)
(Image: Getty/stanciuc)

Related tags: Contract research organization, CRO, Optimapharm, Clinical research, Clinical research services

In a string of expansion announcements, the Croatia-based CRO Optimapharm is now opening new offices in Cambridge, UK.

Earlier this year, the contract research organization (CRO) opened its first office in the US​. As part of the expansion, two new team members joined the team, including Roy Ovel as chief commercial officer and Charles Denis Maher as vice president, business development (Americas).

With offices in 13 countries, Optimapharm is now set to open another office in Cambridge, UK. Additionally, the company has hired a new senior vice president of business development for Europe, EMEA, Israel, and emerging countries, Maxime Stevens.

Ovel said the UK remains a key country for performing clinical trials – and it is important for the CRO to have a presence in the region to further support its clients in the US and across Europe.

Despite the issues with Brexit, there is still considerable demand for trials to be performed in the UK and we expect that the UK will continue to be a leading market for pharmaceuticals as well as a strong contributor to the clinical research community,”​ he told us.

“The company has opened its first office in the country, and it will be from this hub that we continue to expand our commercial and operational presence in the country to continue support our client’s needs in the region,”​ Ovel added.

The company also acquired MKS Research in January 2018​ with plans to double its revenue and become the largest independent CRO in the Central and Eastern Europe (CEE) and South East Europe (SEE) regions.

Related news

Show more

Related products

show more

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Baxter’s Oncology Contract Manufacturing

Baxter’s Oncology Contract Manufacturing

Baxter BioPharma Solutions | 29-Aug-2018 | Product Brochure

Baxter BioPharma Solutions’ FOYA award-winning facility in Halle/Westfalen, Germany, offers state-of-the-art parenteral cGMP manufacturing at one location,...

Related suppliers

Follow us

Products

View more

Webinars